217 related articles for article (PubMed ID: 33051659)
21. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.
Opotowsky AR; Moko LE; Ginns J; Rosenbaum M; Greutmann M; Aboulhosn J; Hageman A; Kim Y; Deng LX; Grewal J; Zaidi AN; Almansoori G; Oechslin E; Earing M; Landzberg MJ; Singh MN; Wu F; Vaidya A
J Clin Endocrinol Metab; 2015 Apr; 100(4):1325-34. PubMed ID: 25581599
[TBL] [Abstract][Full Text] [Related]
22. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.
Yamazaki Y; Gao X; Pecori A; Nakamura Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Satoh F; Sasano H
Front Endocrinol (Lausanne); 2020; 11():587769. PubMed ID: 33193100
[TBL] [Abstract][Full Text] [Related]
23. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
[TBL] [Abstract][Full Text] [Related]
24. Coexistence of paraganglioma/pheochromocytoma and papillary thyroid carcinoma: a four-case series analysis.
Bugalho MJ; Silva AL; Domingues R
Fam Cancer; 2015 Dec; 14(4):603-7. PubMed ID: 26071763
[TBL] [Abstract][Full Text] [Related]
25. A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma.
Burnichon N; Lepoutre-Lussey C; Laffaire J; Gadessaud N; Molinié V; Hernigou A; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
Eur J Endocrinol; 2011 Jan; 164(1):141-5. PubMed ID: 20923864
[TBL] [Abstract][Full Text] [Related]
26. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.
Vicha A; Musil Z; Pacak K
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210
[TBL] [Abstract][Full Text] [Related]
27. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study.
Schovanek J; Martucci V; Wesley R; Fojo T; Del Rivero J; Huynh T; Adams K; Kebebew E; Frysak Z; Stratakis CA; Pacak K
BMC Cancer; 2014 Jul; 14():523. PubMed ID: 25048685
[TBL] [Abstract][Full Text] [Related]
28. Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study.
van der Tuin K; Mensenkamp AR; Tops CMJ; Corssmit EPM; Dinjens WN; van de Horst-Schrivers ANA; Jansen JC; de Jong MM; Kunst HPM; Kusters B; Leter EM; Morreau H; van Nesselrooij BMP; Oldenburg RA; Spruijt L; Hes FJ; Timmers HJLM
J Clin Endocrinol Metab; 2018 Feb; 103(2):438-445. PubMed ID: 29177515
[TBL] [Abstract][Full Text] [Related]
29. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
30. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
[TBL] [Abstract][Full Text] [Related]
31. Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.
Flynn A; Dwight T; Harris J; Benn D; Zhou L; Hogg A; Catchpoole D; James P; Duncan EL; Trainer A; Gill AJ; Clifton-Bligh R; Hicks RJ; Tothill RW
J Clin Endocrinol Metab; 2016 Mar; 101(3):1034-43. PubMed ID: 26796762
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
Casey RT; Warren AY; Martin JE; Challis BG; Rattenberry E; Whitworth J; Andrews KA; Roberts T; Clark GR; West H; Smith PS; Docquier FM; Rodger F; Murray V; Simpson HL; Wallis Y; Giger O; Tran M; Tomkins S; Stewart GD; Park SM; Woodward ER; Maher ER
J Clin Endocrinol Metab; 2017 Nov; 102(11):4013-4022. PubMed ID: 28973655
[TBL] [Abstract][Full Text] [Related]
33. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
Benn DE; Richardson AL; Marsh DJ; Robinson BG
Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
[TBL] [Abstract][Full Text] [Related]
34. CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
Turkova H; Prodanov T; Maly M; Martucci V; Adams K; Widimsky J; Chen CC; Ling A; Kebebew E; Stratakis CA; Fojo T; Pacak K
Endocr Pract; 2016 Mar; 22(3):302-14. PubMed ID: 26523625
[TBL] [Abstract][Full Text] [Related]
35. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
36. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.
Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y
Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715
[TBL] [Abstract][Full Text] [Related]
37. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
[TBL] [Abstract][Full Text] [Related]
38. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
Moraitis AG; Martucci VL; Pacak K
Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
[TBL] [Abstract][Full Text] [Related]
39. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
40. A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma.
Scollo C; Russo M; De Gregorio L; Terranova R; Mangione E; Castoro C; Squatrito S; Pellegriti G
Endocr J; 2016; 63(1):87-91. PubMed ID: 26497911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
